MDLNMedline Inc.

$34.08

What is the market doing?

Mixed

No clear lean: nothing decisive, though in a downtrend (−15% vs 200-day).

1 to watch, 2 neutral
TrendDowntrendderived · Oct 23, 2026

In a downtrend, below its 50- and 200-day averages. Price is −15% vs its 200-day average.

Insider conviction−$1.2B (90 days to Oct 22, 2026)SEC EDGAR · Oct 22, 2026

Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).

Short interest6.4% of sharesFINRA · Sep 30, 2026

Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 28% since the previous count, up from 4.4% of shares outstanding three months ago.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

vs 200-day avgbehind 78% of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How MDLN is trading

vs 200-day average
−15%

vs 200-day average · a clear downtrend

RSI (14)
35

RSI (14) · neutral

Below its 52-week high
32%

Below its 52-week high

Dec 17, 2025$31.61 – $49.99 · dashed line: 200-day averageOct 23, 2026
Details›
Last close2026-10-23
$34.08
1 monthS&P 500 −0.94%
−1.7%
vs 50-day average$34.70
−1.8%
52-week high
$49.99
52-week low
$31.61
Annualised volatility
44%
Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
$4.75B

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

Where the price stands

Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.